294 related articles for article (PubMed ID: 32011657)
1. Structural and biochemical evaluation of bisubstrate inhibitors of protein arginine N-methyltransferases PRMT1 and CARM1 (PRMT4).
Gunnell EA; Al-Noori A; Muhsen U; Davies CC; Dowden J; Dreveny I
Biochem J; 2020 Feb; 477(4):787-800. PubMed ID: 32011657
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibitors that discriminate between protein arginine N-methyltransferases PRMT1 and CARM1.
Dowden J; Pike RA; Parry RV; Hong W; Muhsen UA; Ward SG
Org Biomol Chem; 2011 Oct; 9(22):7814-21. PubMed ID: 21952734
[TBL] [Abstract][Full Text] [Related]
3. Transient Kinetics Define a Complete Kinetic Model for Protein Arginine Methyltransferase 1.
Hu H; Luo C; Zheng YG
J Biol Chem; 2016 Dec; 291(52):26722-26738. PubMed ID: 27834681
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for CARM1 inhibition by indole and pyrazole inhibitors.
Sack JS; Thieffine S; Bandiera T; Fasolini M; Duke GJ; Jayaraman L; Kish KF; Klei HE; Purandare AV; Rosettani P; Troiani S; Xie D; Bertrand JA
Biochem J; 2011 Jun; 436(2):331-9. PubMed ID: 21410432
[TBL] [Abstract][Full Text] [Related]
5. Nη-substituted arginyl peptide inhibitors of protein arginine N-methyltransferases.
Lakowski TM; 't Hart P; Ahern CA; Martin NI; Frankel A
ACS Chem Biol; 2010 Nov; 5(11):1053-63. PubMed ID: 20701328
[TBL] [Abstract][Full Text] [Related]
6. The protein arginine methyltransferases CARM1 and PRMT1 cooperate in gene regulation.
Kleinschmidt MA; Streubel G; Samans B; Krause M; Bauer UM
Nucleic Acids Res; 2008 Jun; 36(10):3202-13. PubMed ID: 18413343
[TBL] [Abstract][Full Text] [Related]
7. Transition state mimics are valuable mechanistic probes for structural studies with the arginine methyltransferase CARM1.
van Haren MJ; Marechal N; Troffer-Charlier N; Cianciulli A; Sbardella G; Cavarelli J; Martin NI
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3625-3630. PubMed ID: 28330993
[TBL] [Abstract][Full Text] [Related]
8. Structural Insights into Ternary Complex Formation of Human CARM1 with Various Substrates.
Boriack-Sjodin PA; Jin L; Jacques SL; Drew A; Sneeringer C; Scott MP; Moyer MP; Ribich S; Moradei O; Copeland RA
ACS Chem Biol; 2016 Mar; 11(3):763-71. PubMed ID: 26551522
[TBL] [Abstract][Full Text] [Related]
9. In situ generation of a bisubstrate analogue for protein arginine methyltransferase 1.
Osborne T; Roska RL; Rajski SR; Thompson PR
J Am Chem Soc; 2008 Apr; 130(14):4574-5. PubMed ID: 18338885
[TBL] [Abstract][Full Text] [Related]
10. Novel inhibitors for PRMT1 discovered by high-throughput screening using activity-based fluorescence polarization.
Dillon MB; Bachovchin DA; Brown SJ; Finn MG; Rosen H; Cravatt BF; Mowen KA
ACS Chem Biol; 2012 Jul; 7(7):1198-204. PubMed ID: 22506763
[TBL] [Abstract][Full Text] [Related]
11. Understanding protein arginine methyltransferase 1 (PRMT1) product specificity from molecular dynamics.
Gathiaka S; Boykin B; Cáceres T; Hevel JM; Acevedo O
Bioorg Med Chem; 2016 Oct; 24(20):4949-4960. PubMed ID: 27545444
[TBL] [Abstract][Full Text] [Related]
12. Virtual Screening with a Structure-Based Pharmacophore Model to Identify Small-Molecule Inhibitors of CARM1.
Ran T; Li W; Peng B; Xie B; Lu T; Lu S; Liu W
J Chem Inf Model; 2019 Jan; 59(1):522-534. PubMed ID: 30607947
[TBL] [Abstract][Full Text] [Related]
13. Structural studies of protein arginine methyltransferase 2 reveal its interactions with potential substrates and inhibitors.
Cura V; Marechal N; Troffer-Charlier N; Strub JM; van Haren MJ; Martin NI; Cianférani S; Bonnefond L; Cavarelli J
FEBS J; 2017 Jan; 284(1):77-96. PubMed ID: 27879050
[TBL] [Abstract][Full Text] [Related]
14. Biochemical control of CARM1 enzymatic activity by phosphorylation.
Feng Q; He B; Jung SY; Song Y; Qin J; Tsai SY; Tsai MJ; O'Malley BW
J Biol Chem; 2009 Dec; 284(52):36167-36174. PubMed ID: 19843527
[TBL] [Abstract][Full Text] [Related]
15. Investigating the binding preferences of small molecule inhibitors of human protein arginine methyltransferase 1 using molecular modelling.
Hong W; Li J; Laughton CA; Yap LF; Paterson IC; Wang H
J Mol Graph Model; 2014 Jun; 51():193-202. PubMed ID: 24937176
[TBL] [Abstract][Full Text] [Related]
16. The Development of Tetrazole Derivatives as Protein Arginine Methyltransferase I (PRMT I) Inhibitors.
Sun Y; Wang Z; Yang H; Zhu X; Wu H; Ma L; Xu F; Hong W; Wang H
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31390828
[TBL] [Abstract][Full Text] [Related]
17. Protein arginine methyltransferase 1: positively charged residues in substrate peptides distal to the site of methylation are important for substrate binding and catalysis.
Osborne TC; Obianyo O; Zhang X; Cheng X; Thompson PR
Biochemistry; 2007 Nov; 46(46):13370-81. PubMed ID: 17960915
[TBL] [Abstract][Full Text] [Related]
18. A protein arginine N-methyltransferase 1 (PRMT1) and 2 heteromeric interaction increases PRMT1 enzymatic activity.
Pak ML; Lakowski TM; Thomas D; Vhuiyan MI; Hüsecken K; Frankel A
Biochemistry; 2011 Sep; 50(38):8226-40. PubMed ID: 21851090
[TBL] [Abstract][Full Text] [Related]
19. A novel splicing isoform of protein arginine methyltransferase 1 (PRMT1) that lacks the dimerization arm and correlates with cellular malignancy.
Patounas O; Papacharalampous I; Eckerich C; Markopoulos GS; Kolettas E; Fackelmayer FO
J Cell Biochem; 2018 Feb; 119(2):2110-2123. PubMed ID: 28857308
[TBL] [Abstract][Full Text] [Related]
20. Type I Arginine Methyltransferases PRMT1 and PRMT-3 Act Distributively.
Kölbel K; Ihling C; Bellmann-Sickert K; Neundorf I; Beck-Sickinger AG; Sinz A; Kühn U; Wahle E
J Biol Chem; 2009 Mar; 284(13):8274-82. PubMed ID: 19158082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
